Skip to content
OpenCapital
Get started

Cardinal Health CAH Cost of product sold — Revenue

Other segment segments

Pharmaceutical and Specialty Solutions
$56.11B+11.3%
Other Segments
$1.71B+30.8%

Similar metrics at other companies

Solventum logo
SOLVCost of product — Total Net Sales
$1.51B-5.3%
Bausch Health Companies logo
BHCProduct sales — Revenue
$2.5B+12.3%
Innovex International logo
INVXProduct — Cost Of Revenue
$123.25M+3.0%
Charles River Laboratories logo
CRLCost of products sold (excluding amortization of intangible assets) — Total Revenue
$197.68M+6.1%
Bruker logo
BRKRProduct — Cost Of Revenue
$347.6M+7.8%
NOVA, Inc. logo
NOVProduct — Cost Of Revenue
$1.21B+2.0%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%—
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's cost of product sold — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's cost of product sold — revenue?
Cardinal Health (CAH) reported cost of product sold — revenue of $3.15B in Q1 2026.
How has Cardinal Health's cost of product sold — revenue changed year-over-year?
Cardinal Health's cost of product sold — revenue decreased by 0.4% year-over-year, from $3.16B to $3.15B.
What is the long-term trend for Cardinal Health's cost of product sold — revenue?
Over 2 years (2022 to 2025), Cardinal Health's cost of product sold — revenue has grown at a -2.5% compound annual growth rate (CAGR), from $13.28B to $12.64B.
What does cost of product sold — revenue mean?
This metric represents the total revenue generated by the cost of product sold segment. It captures the gross inflow of economic benefits from the sale of pharmaceutical and medical-surgical products within this specific business unit.